- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03100617
Alzheimer's Family Caregiver Intervention in Vietnam
August 20, 2020 updated by: University of California, Davis
Single Arm Study of Modified REACH-VA Alzheimer's Caregiver Intervention in Vietnam
This is a single arm pilot study of 6-8 families to test the feasibility and acceptability of a Alzheimer's family caregiver intervention in Vietnam.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single arm pilot study of 6-8 families to test the feasibility and acceptability of a modified version of the REACH-VA caregiver intervention in Vietnam.
The REACH-VA caregiver intervention is an evidence-based intervention that has been shown to be effective in multicultural populations in the US.
The model has been modified for use in Vietnam.
This study will test the modified model in Vietnam.
Participants in this study will be adult family caregivers of non-institutionalized persons with dementia who are living in Hanoi, Vietnam.
They will receive 4-6 sessions delivered over the course of 2-3 months that will included the following components: 1) education about the nature of the disease, 2) risk assessment, 3) enhancing caregiver skills and problem-solving, and 4) caregiver stress reduction.
The intervention will be delivered by a social worker or nurse using a Vietnamese language versions of the REACH-VA protocol and caregiver intervention notebook.
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hanoi, Vietnam
- Vietnam National Geriatric Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary adult family caregiver of person with dementia
Exclusion Criteria:
- Caregivers of persons with dementia who are institutionalized
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: REACH-VA family caregiver intervention
Behavioral intervention with several components including 1) caregiver education, 2) risk assessment, 3) caregiver needs assessment, 4) caregiver skill building and problem solving, and 4) caregiver stress reduction.
|
Modified version of the REACH-VA intervention for family caregivers of persons with dementia.
The intervention has several components including 1) caregiver education, 2) risk assessment, 3) caregiver needs assessment, 4) caregiver skill building and problem solving, and 4) caregiver stress reduction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Caregiver Burden
Time Frame: Change from baseline Zarit burden scale score to 3 months.
|
Zarit Burden scale
|
Change from baseline Zarit burden scale score to 3 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 26, 2017
Primary Completion (Actual)
June 18, 2018
Study Completion (Actual)
June 18, 2018
Study Registration Dates
First Submitted
March 24, 2017
First Submitted That Met QC Criteria
March 28, 2017
First Posted (Actual)
April 4, 2017
Study Record Updates
Last Update Posted (Actual)
September 2, 2020
Last Update Submitted That Met QC Criteria
August 20, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1084736
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia Alzheimers
-
Washington University School of MedicineEli Lilly and Company; Hoffmann-La Roche; Avid Radiopharmaceuticals; National Institute... and other collaboratorsRecruitingDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, Italy, Argentina, Australia, Brazil, Colombia, France, Germany, Ireland, Japan, Mexico, Netherlands, Puerto Rico, Spain, United Kingdom
-
Washington University School of MedicineNational Institute on Aging (NIA); Alzheimer's Association; Eisai Inc.; Accelerating...RecruitingDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, Italy, Argentina, Australia, Colombia, Netherlands, Puerto Rico, Spain, United Kingdom, France, Ireland, Mexico, Brazil, Japan, Germany
-
Maastricht UniversityRadboud University Medical CenterCompletedDementia | Dementia Alzheimers | Dementia, MildNetherlands
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Alzinova ABCRST OyRecruitingAlzheimer Disease | Dementia Alzheimers | Dementia, MildFinland
-
BaycrestCompleted
-
University of California, Los AngelesNational Institute on Aging (NIA)Enrolling by invitationAlzheimer Disease | Dementia Alzheimers | Dementia of Alzheimer TypeUnited States
-
Washington University School of MedicineEli Lilly and Company; Hoffmann-La Roche; Avid Radiopharmaceuticals; National Institute... and other collaboratorsCompletedDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, France, Spain, Ireland, Australia, Puerto Rico, United Kingdom
-
University of AberdeenNHS Grampian; Tenovus ScotlandCompleted
-
Boryung Pharmaceutical Co., LtdCompletedDementia AlzheimersKorea, Republic of
Clinical Trials on Psychosocial caregiver intervention
-
University of WashingtonNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
University of ManchesterUnknownStudy of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung CancerDepression | Fatigue | Lung Cancer | Dyspnea | Anxiety DisorderUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnDepression | Fatigue | Anxiety Disorder
-
Eunice Kennedy Shriver National Institute of Child...Autism SpeaksCompletedAutism Spectrum DisorderUnited States
-
City of Hope Medical CenterCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedDepression | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Anxiety Disorder | Psychosocial Effects of Cancer and Its Treatment | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in SituUnited States
-
Duke UniversityCompletedCaregiver WellbeingUnited States
-
Georgia State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); University...CompletedDevelopmental DisabilitySouth Africa